Australia's decision-making framework is dominated by a single-payer that exercises its extraordinary power through HTA. Managing the reality of this power asymmetry is critical for the proponents of change.
Power asymmetry is the biggest issue for advocates of HTA reform
October 28, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
It happened last time, so it makes sense to start next week assuming it as the base case
November 21, 2026 - - Latest News -
Wegovy pill available in Australia from today by private prescription
November 20, 2026 - - Latest News -
Applying the principles of the Reserve Bank review to HTA advisory committees
November 20, 2026 - - Latest News -
Government turns again to cheaper medicines as Guild eyes co-payment freeze
November 19, 2026 - - Latest News -
Moderna's mRNA flu vaccines and a GLP-1 review headline March PBAC agenda
November 19, 2026 - - Latest News -
New Zealand risks losing $763 million clinical trials sector as other countries step up
November 19, 2026 - -
A tale of two government programs - one held flat and the other still running hot
November 19, 2026 - - Latest News

